no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Call for papers, Vaccine Congress, Celebrating 25 Years of Publication, 9-11 December 2007, Amsterdam, The Netherlands
|
|
|
2007 |
25 |
25 |
p. 4861- 1 p. |
article |
2 |
Chimeric tymovirus-like particles displaying foot-and-mouth disease virus non-structural protein epitopes and its use for detection of FMDV-NSP antibodies
|
Hema, Masarapu |
|
2007 |
25 |
25 |
p. 4784-4794 11 p. |
article |
3 |
Comparative evaluation of a bivalent killed Salmonella vaccine to prevent egg contamination with Salmonella enterica serovars Enteritidis, Typhimurium, and Gallinarum biovar Pullorum, using 4 different challenge models
|
Okamura, Masashi |
|
2007 |
25 |
25 |
p. 4837-4844 8 p. |
article |
4 |
Comparative reactogenicity and immunogenicity of 23 valent pneumococcal vaccine administered by intramuscular or subcutaneous injection in elderly adults
|
Cook, Ian F. |
|
2007 |
25 |
25 |
p. 4767-4774 8 p. |
article |
5 |
Editorial Board/Aims and Scope
|
|
|
2007 |
25 |
25 |
p. CO2- 1 p. |
article |
6 |
Enhanced delivery of immunoliposomes to human dendritic cells by targeting the multilectin receptor DEC-205
|
Badiee, Ali |
|
2007 |
25 |
25 |
p. 4757-4766 10 p. |
article |
7 |
Evaluation of antitumor immunity efficacy of epitope-based vaccine with B16 cell line coexpressing HLA-A2/H-2kb and CTL multiepitope in HLA transgenic mice
|
Song, Shuxia |
|
2007 |
25 |
25 |
p. 4853-4860 8 p. |
article |
8 |
Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a
|
Shim, Doo-Hee |
|
2007 |
25 |
25 |
p. 4828-4836 9 p. |
article |
9 |
Improvement of a commercial foot-and-mouth disease vaccine by supplement of Quil A
|
Xiao, Chenwen |
|
2007 |
25 |
25 |
p. 4795-4800 6 p. |
article |
10 |
Influenza vaccination in healthcare workers: A survey of coverage in French cystic fibrosis treatment centres
|
Murris-Espin, Marlène |
|
2007 |
25 |
25 |
p. 4755-4756 2 p. |
article |
11 |
Intranasal cowpox virus infection of the mouse as a model for preclinical evaluation of smallpox vaccines
|
Ferrier-Rembert, Audrey |
|
2007 |
25 |
25 |
p. 4809-4817 9 p. |
article |
12 |
Physico-chemical characterisation and immunogenicity of a multi-valent candidate vaccine against non-typeable Haemophilus influenzae and Moraxella catarrhalis
|
Mawas, Fatme |
|
2007 |
25 |
25 |
p. 4801-4808 8 p. |
article |
13 |
The preclinical testing of a formaldehyde inactivated Ross River virus vaccine designed for use in humans
|
Kistner, Otfried |
|
2007 |
25 |
25 |
p. 4845-4852 8 p. |
article |
14 |
Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge
|
Antonis, Adriaan F.G. |
|
2007 |
25 |
25 |
p. 4818-4827 10 p. |
article |
15 |
Validity of self-reported influenza and pneumococcal vaccination status among a cohort of hospitalized elderly inpatients
|
Skull, Susan A. |
|
2007 |
25 |
25 |
p. 4775-4783 9 p. |
article |